14 completed, 9 unknown, 6 not yet recruiting, 5 recruiting. 20 Not applicable, 6 Phase 4, 5 Phase 3, 3 Phase 2, 1 Phase 1.
Follow Curtin University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing the Transition From Acute to Persistent Disabling Low Back Pain Through Cognitive Functional Therapy Cognitive Functional Therapy (CFT), Usual Care - Acute Low Back Pain (Low Back Pain for Less Than 3 Months) | Not applicable | Not yet recruiting | University of Oulu | 461 | 2027-09-01 | 2026-10-16 |
| Khanya Ekhaya: A Home-Based Intervention Khanya-Ekhaya - Mental Health, Community Health Workers | Not applicable | Active not recruiting | University of Maryland, College Park | 119 | 2026-08-17 | 2026-08-31 |
| Robotic-Assisted Versus Conventional Total Knee Arthroplasty With Virtual Home-Based Rehabilitation Robotic-assisted Total Knee Arthroplasty, Conventional Total Knee Arthroplasty, Hybrid Virtually-Assisted Peri-operative Rehabilitation Program - Osteoarthritis, Knee | Not applicable | Not yet recruiting | Mark Hurworth | 60 | 2026-07-01 | 2026-07-21 |
| Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial Low-dose aspirin, Placebo Comparator - Liver Cirrhosis | Phase 3 | Not yet recruiting | Curtin University | 890 | 2026-06-01 | 2026-04-14 |
| An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria High dose ultra short Primaquine, Placebo - Malaria | Phase 3 | Not yet recruiting | Menzies School of Health Research | 1019 | 2026-06-01 | 2026-03-12 |
| Postpartum 8-aminoquinoline Breast Milk Study Daily primaquine (0.5 mg/kg per day) for 14 days given with food food and water, Daily primaquine 1 mg/kg per day for 7 days given with food and water, Single-dose tafenoquine given with food and water to prevent gastrointestinal discomfort - Drug Pharmacokinetics in Healthy Volunteers | Phase 2 / Phase 3 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-03-18 |
| Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria Single dose tafenoquine (10 mg/kg), Dihydroartemisinin-piperaquine (DHA-PPQ), Artemether + Lumefantrine - Uncomplicated Malaria | Phase 4 | Not yet recruiting | Curtin University | 60 | 2026-04-01 | 2026-02-12 |
| Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children Single dose tafenoquine (10 mg/kg) given with water, Single dose tafenoquine (10 mg/kg) given with fat - Pharmacokinetics of Tafenoquine | Phase 4 | Recruiting | Curtin University | 30 | 2025-10-20 | 2026-03-18 |
| Multisite Virtual Reality Intervention for Speech Anxiety Single-session VR exposure intervention - Public Speaking, Speech Anxiety | Not applicable | Completed | Boston University Charles River Campus | 1542 | 2024-10-08 | 2025-12-18 |
| Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. Patients with G6PD enzyme activities between 30 and <70% of the AMM will be treated with schizontocidal treatment plus high dose primaquine 1mg/kg/day for 7 days, Patients with G6PD enzyme activities <30% of the AMM will be treated with schizontocidal treatment plus 8 weekly primaquine (0.75mg/kg dose). - Vivax Malaria, G6PD Deficiency | Phase 4 | Recruiting | Menzies School of Health Research | 100 | 2024-05-17 | 2026-03-12 |
| A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria Tafenoquine, Primaquine - Vivax Malaria | Phase 3 | Recruiting | Menzies School of Health Research | 1090 | 2024-05-10 | 2025-07-18 |
| A Pilot Study Comparing the Efficacy of Traditional Buddhist Mindfulness Training Versus Secular Mindfulness-based Cognitive Therapy for Patients Having Residual Depressive Symptoms Traditional Buddhist mindfulness, secular mindfulness based cognitive therapy - Depression Moderate, Depression Mild | Not applicable | Unknown | Anuradha Baminiwatta | 60 | 2024-04-01 | 2024-06-13 |
| Upper Limb Somatosensory Discrimination Therapy and Dose-matched Motor Therapy in Children and Adolescents With Unilateral Cerebral Palsy Upper limb somatosensory discrimination therapy, Upper limb motor therapy - Cerebral Palsy, Spastic, Hemiplegic Cerebral Palsy | Phase 2 | Unknown | Hilde Feys | 50 | 2023-12-09 | 2024-02-07 |
| Exposure Therapy Consortium (ETC) for Anxiety Sensitivity Standard Exposure, Stress Management Training, Enhanced Exposure - Elevated Anxiety Sensitivity | Not applicable | Completed | University of Texas at Austin | 399 | 2022-10-01 | 2025-04-29 |
| STICH-3.0 International Trial Consortium Percutaneous Coronary Intervention (PCI) - Coronary Artery Disease, Heart Failure | Not applicable | Recruiting | Vastra Gotaland Region | 2800 | 2022-09-14 | 2024-09-25 |
| Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy Dihydroartemisinin-Piperaquine (DP), Sulfadoxine pyrimethamine (SP) - Malaria, Malaria in Pregnancy | Phase 3 | Active not recruiting | Menzies School of Health Research | 1172 | 2022-08-31 | 2025-06-06 |
| Long-term Use of CCB and Breast Cancer Risk Calcium channel blocker, Beta blocker, Diuretic - Hypertension,Essential, Breast Cancer | Unknown | Curtin University | 68500 | 2022-07-01 | 2024-08-21 | |
| OsteoPreP: Food Supplements for Postmenopausal Bone Health Pendulum WBF-038, Pendulum Placebo - Postmenopausal Osteopenia, Bone Loss, Age Related | Phase 4 | Unknown | Australian Catholic University | 160 | 2022-05-01 | 2024-07-09 |
| Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity. Obesity | Unknown | University of Roma La Sapienza | 400 | 2021-05-13 | 2024-08-26 | |
| COgNitive FuncTional Therapy+ for Chronic Low Back paIn Cognitive Functional Therapy+ pathway, Interdisciplinary pain management pathway - Chronic Low-back Pain | Not applicable | Completed | Odense University Hospital | 133 | 2020-09-27 | 2024-03-25 |
Showing 20 of 38. Sign in to see all of them.
Malaria, Vivax (6) · Low Back Pain (3) · Autism Spectrum Disorder (2) · Breast Feeding (2) · Heart Arrest (2) · Heart Failure (2) · Malaria (2) · Osteoarthritis, Knee (2) · Out-of-Hospital Cardiac Arrest (2) · Pain (2) · Adolescent Behavior (1) · Atrial Fibrillation (1) · Breast Neoplasms (1) · Bronchiectasis (1) · Burnout, Psychological (1)
Primaquine (4) · tafenoquine (4) · Water (2) · Adrenergic beta-Antagonists (1) · Artemether, Lumefantrine Drug Combination (1) · Aspirin (1) · CD36 Antigens (1) · Calcium Channel Blockers (1) · Diuretics (1) · Echocardiography (1) · Educational Status (1) · Electrocardiography (1) · Etoricoxib (1) · Exercise (1) · Food (1)
Australia (16) · Papua New Guinea (8) · Brazil (3) · Ethiopia (3) · United States (3) · China (2) · Germany (2) · Indonesia (2) · Singapore (2) · Belgium (1) · Canada (1) · Denmark (1) · Finland (1) · Ireland (1) · Israel (1)
Brioni R Moore, PhD (2) · Aleksandra Luszczynska, PhD (1) · Annemarie L Lee, PhD (1) · Annina Schmid, MManipTher (1) · Anthony Wright, PhD (1) · Anuradha Baminiwatta, MBBS, MD (1) · Benjamin Soon Tze Chin, MManipTher (1) · Brioni Moore, PhD (1) · Bronwyn Myers, PhD (1) · Celia Tan Ia Choo (1) · Dr Kieran O' Sullivan, PhD (1) · Dr Norelee Kennedy, PhD (1) · Elias Fridriksson, MManipTher (1) · Elisabeth Gresslos, MManipTher (1)
PMID 20122281, PMID 23208945, PMID 24731015, PMID 26033941, PMID 26252343, PMID 27410961, PMID 28778815, PMID 29684433, PMID 31009695, PMID 31630089, PMID 31818252, PMID 33213446, PMID 34003285, PMID 34052908, PMID 36286192, PMID 37269941, PMID 38409060, PMID 38458796, PMID 39649127, PMID 39683612, PMID 40316953, PMID 40516583, PMID 41692033
R21TW012347 (1)